Our system is currently under heavy load due to increased usage. We're actively working on upgrades to improve performance. Thank you for your patience.
2005
DOI: 10.1016/j.surg.2005.04.019
|View full text |Cite
|
Sign up to set email alerts
|

Sodium 4-phenylbutyrate protects against liver ischemia reperfusion injury by inhibition of endoplasmic reticulum-stress mediated apoptosis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

4
110
1

Year Published

2007
2007
2022
2022

Publication Types

Select...
7
2

Relationship

0
9

Authors

Journals

citations
Cited by 137 publications
(120 citation statements)
references
References 45 publications
4
110
1
Order By: Relevance
“…4-PBA is a low molecular weight compound that stabilizes protein conformation, improves folding capacity of the ER and facilitates trafficking of mutant proteins. 31 4-PBA has been demonstrated to reduce the load of mutant or mislocated proteins retained in the ER under conditions associated with cystic fibrosis and liver injury. 25 It is also reported that 4-PBA has a neuroprotective effect on cerebral ischemic injury in a mouse model of ischemia/hypoxia.…”
Section: Discussionmentioning
confidence: 99%
“…4-PBA is a low molecular weight compound that stabilizes protein conformation, improves folding capacity of the ER and facilitates trafficking of mutant proteins. 31 4-PBA has been demonstrated to reduce the load of mutant or mislocated proteins retained in the ER under conditions associated with cystic fibrosis and liver injury. 25 It is also reported that 4-PBA has a neuroprotective effect on cerebral ischemic injury in a mouse model of ischemia/hypoxia.…”
Section: Discussionmentioning
confidence: 99%
“…PBA has multiple biological activities, including as HDAC inhibition [28], chemical chaperoning upon endoplasmic reticulum (ER) stress [38,39], ammonia scavenging in urea cycle dysfunction [31,32]. Urea cycle dysfunction in heart has never been reported after decades of intensive research of ADR cardiotoxicity.…”
Section: Discussionmentioning
confidence: 99%
“…In order to confirm the correlation between apoptosis and the activation of ERS/UPR caused by cholesterol loading in hepatic L02 cells, UPR inhibitor PBA was used to treat cells and then the effects on the apoptotic cell death by cholesterol overloading was observed. PBA, a low-molecule-weight chaperone, stabilizes protein conformation, improves ER folding capacity, and inhibits lipid-induced ERS (37,38), but does not affect cellular lipid contents (13). Moreover, data indicate that the chemical chaperone PBA prevents cell death caused by hypoxia-induced ERS while decreasing CHOP expression (37,39).…”
Section: Discussionmentioning
confidence: 99%
“…PBA, a low-molecule-weight chaperone, stabilizes protein conformation, improves ER folding capacity, and inhibits lipid-induced ERS (37,38), but does not affect cellular lipid contents (13). Moreover, data indicate that the chemical chaperone PBA prevents cell death caused by hypoxia-induced ERS while decreasing CHOP expression (37,39). Thus, PBA typically acts as an inhibitor of UPR.…”
Section: Discussionmentioning
confidence: 99%